Select Committee on Health Minutes of Evidence


Memorandum by British American Tobacco

THE TOBACCO INDUSTRY AND THE HEALTH RISKS OF SMOKING (TB 28)

COMPENSATION

  182.  British American Tobacco has participated from the outset in the wider scientific community's attempt to understand smoking behaviour, and especially the phenomenon of compensation. Among many other initiatives, British American Tobacco hosted one of the first international conferences on smoking behaviour, held at Chelwood in England in 1977. The papers given at the conference, by both British American Tobacco researchers and guest speakers, covered a range of subjects, including the effects of smoking on the central nervous system, methodology in smoking behaviour research, the importance of nicotine in smoking motivation, and the phenomenon of compensation. The conference was attended by more than 50 scientists from all over the world, representing, for example, hospitals in the USA, Canada and the UK, the Universities of Oxford, Cambridge, Southampton, Newcastle and Reading, the London School of Economics, the Medical Research Council's Neuropharmacological Unit, and the Institute of Psychiatry. The audience included the Scientific Secretary to the ISCSH. At the conference, British American Tobacco scientists laid out an important cross-section of the internal smoking behaviour research programme, including details of methodology and instruments used. The proceedings of the conference were published (Thornton, RE "Smoking Behaviour", Churchill Livingstone, Edinburgh, 1978), and were cited by the US Surgeon General in his 1981 and 1988 reports ("The Health Consequences of Smoking: The Changing Cigarette", p 180, 184, 1981; "The Health Consequences of Smoking: Nicotine Addiction", p 58, 1988).

  183.  As a result of its own research, the joint projects with Dr Russell, Dr Stepney of Cambridge University, and others, and its review of the published literature, British American Tobacco has formed views on the duration and extent of compensatory behaviour, and the product characteristics which underpin it.

  184.  It is clear that compensation does occur, but that, as Professor Wald observed (para 174), despite compensation, smokers receive less tar on average when switching to a lower tar cigarette. The extent to which compensation occurs, and how long it lasts, are issues which are less well understood. Much of the early evidence for compensation came from experimental or observational brand-switching studies from a period when smokers of High or Middle tar products increased their average puff volume when trying to adjust down from products in the tar bands to which they were accustomed. In the experimental studies, the switching was often not voluntary. In both types of study, it is likely that smokers were often switching away from a product they preferred. In addition, almost all of these studies were relatively short-term (ie the observations took place over a period of weeks rather than months or years).

  185.  The evidence suggests that increasing the number of cigarettes consumed, blocking of ventilation holes and increasing inhalation depth, are not common compensation mechanisms. Compensation seems generally to take place at the puffing stage (ie through larger puff volumes).

  186.  Even today, little is known about the duration of compensatory behaviour. Few published studies have tracked smokers who have changed to brands with different tar levels for even a year. The limited evidence of which we are aware, suggests that switched smokers either revert gradually to their former, non-compensatory behaviour (which results in lower overall intake of smoke), or change again to a brand which they prefer and which does not require the extra "effort" of taking larger puffs (which may or may not result in lower intake).

  187.  It should also be noted that many current adult smokers have been accustomed to low tar brands since relatively early in their smoking history. Many do not exhibit a preference for old, high taste and strength-style products, and observational evidence is that they do not seem to exhibit characteristic over smoking seen in typical compensatory behaviour; that is to say, puff volume does not appear to correlate with tar or nicotine yield. This implies either that many smokers of low tar brands have never "compensated" or that, if they once did, they have now stopped. However, this is an area where further research is needed.

  188.  Similarly, the question of what provokes compensatory behaviour is still the subject of investigation. Many adhere to the hypothesis that smokers compensate either to regulate their nicotine uptake over a period of time, or to derive from the lower delivery product the nicotine "peaks" to which they were formerly accustomed. However, there is accumulating evidence that compensatory behaviour is primarily stimulated by reductions in other smoke components which are responsible for the taste and body of the smoke, and its sensory effects at the puffing stage. Another factor may be the draw resistance associated with lower yield products. These views are consistent with a recent review of the scientific literature (Scherer G, "Smoking Behaviour and Compensation: A Review of the Literature," Psychopharmacology, 145:1, 1999).


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries

© Parliamentary copyright 2000
Prepared 28 February 2000